Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Calcitriol may cause prostate cancer cells to look more like normal cells, and to
grow and spread more slowly. Drugs used in chemotherapy, such as mitoxantrone and prednisone,
work in different ways to stop the growth of tumor cells, either by killing the cells or by
stopping them from dividing.
PURPOSE: This phase II trial is studying how well giving calcitriol together with
mitoxantrone and prednisone works in treating patients with metastatic prostate cancer.